Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer

被引:48
作者
Merlano, Marco C. [1 ]
Monteverde, Martino [1 ]
Colantonio, Ida
Denaro, Nerina [5 ]
Lo Nigro, Cristiana [1 ]
Natoli, Guido
Giurlanda, Francesco [2 ]
Numico, Gianmauro [3 ]
Russi, Elvio [4 ]
机构
[1] S Croce Gen Hosp, Dept Med Oncol, Translat Oncol Lab, I-12100 Cuneo, Italy
[2] S Croce Gen Hosp, Dept Med Oncol, Clin Trials Off, I-12100 Cuneo, Italy
[3] Aosta Gen Hosp, Dept Med Oncol, Aosta, Italy
[4] S Croce Gen Hosp, Dept Radiat Therapy, I-12100 Cuneo, Italy
[5] Univ Messina, Dept Human Pathol, I-98100 Messina, Italy
关键词
Chemoradiation toxicity; Age; Head and neck cancer; SQUAMOUS-CELL CARCINOMA; ALTERNATING CHEMOTHERAPY; RADIOTHERAPY;
D O I
10.1016/j.oraloncology.2012.05.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The purpose of this study is to retrospectively analyze acute toxicity encountered in young and old patients treated with chemo-radiation or bio-radiation at the S. Croce General Hospital between 1997 and 2008, in daily clinical practice. Material and methods: Three hundred and seventeen patients were allocated into two groups according to age (cut-off 65 years). The two groups were compared in terms of treatment related toxicities, treatment activity and efficacy. Epidermal Growth factor receptor (EGFr), Human papillomavirus (HPV) and p53 status were also considered. Results: As expected, overall survival was significantly worse in elderly patients (p = 0.005), but response rate, including complete response rate, was similar between the two age groups, as were most of the side effects analyzed. However, infections (p = 0.011) and in particular pneumonias (p = 0.002) were significantly more represented in elderly patients. Conclusion: Elderly patients treated with chemo-radiation or bio-radiation in our centre had a higher risk of infection and in particular, pneumonia. These data suggest a more careful follow-up, but age alone does not justify their exclusion from treatment. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1051 / 1057
页数:7
相关论文
共 13 条
[1]  
[Anonymous], PACLITAXEL CIS UNPUB
[2]   p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis [J].
Bergamaschi, D ;
Gasco, M ;
Hiller, L ;
Sullivan, A ;
Syed, N ;
Trigiante, G ;
Yulug, I ;
Merlano, M ;
Numico, G ;
Comino, A ;
Attard, M ;
Reelfs, O ;
Gusterson, B ;
Bell, AK ;
Heath, V ;
Tavassoli, M ;
Farrell, PJ ;
Smith, P ;
Lu, X ;
Crook, T .
CANCER CELL, 2003, 3 (04) :387-402
[3]   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[4]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[5]   Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].
Bonner, James A. ;
Harari, Paul M. ;
Giralt, Jordi ;
Cohen, Roger B. ;
Jones, Christopher U. ;
Sur, Ranjan K. ;
Raben, David ;
Baselga, Jose ;
Spencer, Sharon A. ;
Zhu, Junming ;
Youssoufian, Hagop ;
Rowinsky, Eric K. ;
Ang, K. Kian .
LANCET ONCOLOGY, 2010, 11 (01) :21-28
[6]  
Ekberg O., 1991, AJR, V156, P293
[7]   Concurrent chemoradiation in the treatment of head and neck cancer [J].
Haffty, BG .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (04) :719-+
[8]   Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy [J].
Lefebvre, J. L. ;
Rolland, F. ;
Tesselaar, M. ;
Bardet, E. ;
Leemans, C. R. ;
Geoffrois, L. ;
Hupperets, P. ;
Barzan, L. ;
de Raucourt, D. ;
Chevalier, D. ;
Licitra, L. ;
Lunghi, F. ;
Stupp, R. ;
Lacombe, D. ;
Bogaerts, J. ;
Horiot, J. C. ;
Bernier, J. ;
Vermorken, J. B. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (03) :142-152
[9]   TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH ALTERNATING CHEMOTHERAPY AND RADIOTHERAPY [J].
MERLANO, M ;
VITALE, V ;
ROSSO, R ;
BENASSO, M ;
CORVO, R ;
CAVALLARI, M ;
SANGUINETI, G ;
BACIGALUPO, A ;
BADELLINO, F ;
MARGARINO, G ;
BREMA, F ;
PASTORINO, G ;
MARZIANO, C ;
GRIMALDI, A ;
SCASSO, F ;
SPERATI, G ;
PALLESTRINI, E ;
GARAVENTA, G ;
ACCOMANDO, E ;
CORDONE, G ;
COMELLA, G ;
DAPONTE, A ;
RUBAGOTTI, A ;
BRUZZI, P ;
SANTI, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16) :1115-1121
[10]   Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients [J].
Pignon, Jean-Pierre ;
le Maitre, Aurelie ;
Maillard, Emilie ;
Bourhis, Jean .
RADIOTHERAPY AND ONCOLOGY, 2009, 92 (01) :4-14